RxDoctor Payments Data

Kayla Kittle, MD

Family Medicine · Bolivar, MONPI 1437679560

Payments from drug & device makers

$995in general payments, 2019–2025

Across 62 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242
  • Novo Nordisk$123
  • Lilly USA, LLC$116
  • Pfizer$104
  • Organon$78
  • Biohaven Pharmaceutical Holding Company Ltd.$47
  • plus $285 from 14 others

What the payments were for

  • Food & beverage$995100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$995 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$46,331
Medicare patients
103
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$29,998
VraylarCariprazine Hcl16$25,184
JardianceEmpagliflozin27$23,972
MounjaroTirzepatide15$20,120
EliquisApixaban12$19,677
JanuviaSitagliptin Phosphate12$15,668
LinzessLinaclotide27$14,295
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,958
XareltoRivaroxaban12$6,711
SavellaMilnacipran Hcl11$5,273
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen67$2,502
Gabapentin128$2,315
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen101$1,484
Albuterol Sulfate HfaAlbuterol Sulfate66$1,416
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess, Savella$242$44,75254 claims
Novo NordiskOzempic$123$29,99827 claims
Lilly USA, LLCMounjaro$116$20,12015 claims
PfizerEliquis$104$19,67712 claims
AstraZenecaBreztri Aerosphere$14$6,95811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Bolivar

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →